Colorectal cancer Posts on Medivizor
Navigation Menu

Colorectal cancer Posts on Medivizor

Oral mucositis caused by targeted therapy for colorectal cancer: which drug is safer?

Posted by on Nov 4, 2018 in Colorectal cancer | 0 comments

In a nutshell This study investigated the frequency and severity of oral mucositis (OM) in patients with colorectal cancer treated with chemotherapy and panitumumab (Vectibix) or cetuximab (Erbitux). Researchers suggested that panitumumab ?is associated with increased levels of OM in these patients. Some background Colorectal cancer is the fourth...

Read More

Adding mFOLFOX6 to the standard treatment for rectal cancer increases cancer response and survival

Posted by on Oct 29, 2018 in Colorectal cancer | 0 comments

In a nutshell This study investigated whether adding mFOLFOX6 (modified; folinic acid, fluorouracil, and oxaliplatin) chemotherapy after standard chemotherapy and radiotherapy (CRT) and delaying surgery improves cancer response and survival in rectal cancer. Researchers suggest that this treatment increases disease-free survival (DFS;...

Read More

Laparoscopic surgery is associated with improved quality of life in patients with colon cancer

Posted by on Oct 27, 2018 in Colorectal cancer | 0 comments

In a nutshell This study compared open surgery to laparoscopic surgery (LS; a tube with a camera is inserted through a small cut to remove the tumor) in terms of quality of life in patients with colon cancer. Researchers suggested that patients treated with LS had an improved quality of life after surgery.   Some background Colon cancer is...

Read More

Radiotherapy improves cancer outcomes in patients with advanced colorectal cancer

Posted by on Oct 27, 2018 in Colorectal cancer | 0 comments

In a nutshell This study investigated the effectiveness and safety of radiotherapy in patients with metastatic (spread to other parts of the body) colorectal cancer (mCRC). Researchers suggested that radiotherapy could be a safe option for the treatment of these patients. Some background Colorectal cancer is the third most frequently diagnosed cancer....

Read More

Laparoscopic conversion is not associated with increased complications in patients with colon cancer

Posted by on Oct 21, 2018 in Colorectal cancer | 0 comments

In a nutshell This study investigated whether laparoscopic conversion (LC) was associated with an increased complication rate when compared to planned open colon surgery. Researchers suggested that this treatment method is not associated with an increased risk of negative side effects. Some background Laparoscopic surgery is a less invasive method. It...

Read More

Cognitive performance is affected by chemotherapy in patients with colorectal cancer

Posted by on Oct 20, 2018 in Colorectal cancer | 0 comments

In a nutshell This study investigated the effects of chemotherapy after surgery on cognitive performance (CP; attention, memory and thinking processes) in patients with colorectal cancer. Researchers suggested that patients who received chemotherapy after surgery had a decreased CP. Some background Surgery followed by chemotherapy is the standard...

Read More

Evaluating Cetuximab plus FOLFOX-4 chemotherapy for patients with metastatic colorectal cancer

Posted by on Oct 13, 2018 in Colorectal cancer | 0 comments

In a nutshell This study investigated the effectiveness of cetuximab (Erbitux) combined with FOLFOX-4 (leucovorin, fluorouracil, and oxaliplatin) chemotherapy to treat metastatic (spread to other parts of the body) colorectal cancer (mCRC). Researchers suggested that this treatment is associated with improved cancer outcomes. Some background...

Read More

Local treatment in metastatic colorectal cancer is a safe option for the elderly and for patients with other medical conditions

Posted by on Oct 13, 2018 in Colorectal cancer | 0 comments

In a nutshell This study investigated whether local ablative methods (LAT; non-invasive procedures) of treatment can be used in patients with colorectal cancer that are older or have other medical conditions. Researchers suggested that these procedures may be performed safely in these patients. Some background Age is a major risk factor for colorectal...

Read More

What is the best treatment for patients with colorectal cancer and peritoneal metastasis?

Posted by on Sep 29, 2018 in Colorectal cancer | 0 comments

In a nutshell This study compared the effectiveness of cytoreductive surgery (CRS) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) with other treatment options in patients with colorectal cancer (CRC) and peritoneal metastasis (PM; when cancer spreads to the abdominal lining). Researchers suggested that CRS + HIPEC brings the greatest...

Read More

Chemotherapy before surgery in the treatment of high risk rectal cancer

Posted by on Sep 15, 2018 in Colorectal cancer | 0 comments

In a nutshell This study investigated the outcomes of chemotherapy before surgery in patients with high-risk rectal cancer. Researchers suggested that chemotherapy improves tumor shrinkage before rectal surgery.   Some background The standard treatment for patients with rectal cancer is surgery. High-risk patients may benefit from short-course...

Read More

Does chemotherapy after surgery improve survival in older patients with colon cancer?

Posted by on Sep 13, 2018 in Colorectal cancer | 0 comments

In a nutshell This study investigated the use of chemotherapy after surgery in elderly patients with stage 2 and 3 colon cancer. Researchers suggested that chemotherapy after surgery improves outcomes in patients with stage 3 colon cancer. Some background Life expectancy in the Western countries has increased. Colorectal cancer is diagnosed most...

Read More

“Your Life Depends on Your Own Advocacy”

“Your Life Depends on Your Own Advocacy”

Posted by on Sep 10, 2018 in Blog, Breast cancer, Colorectal cancer, Hodgkin's lymphoma, Leukemia, Lung cancer, Lymphoma, Melanoma, Multiple Myeloma, Non-Hodgkin lymphoma, Prostate cancer | 1 comment

“Always trust your gut. Don’t leave your treatment in the hands of someone that you don’t trust or that does not seem like a team player. Yes, they are all smart—even brilliant—but read, read, read, and question them at every corner and challenge the standard of care. Exercise, healthy eating, learning the ropes of insurance, mediation/prayer...

Read More